Marsenic et al., 2010 - Google Patents
Application of individualized Bayesian urea kinetic modeling to pediatric hemodialysisMarsenic et al., 2010
View PDF- Document ID
- 9657297784473436070
- Author
- Marsenic O
- Zhang L
- Zuppa A
- Barrett J
- Pfister M
- Publication year
- Publication venue
- ASAIO Journal
External Links
Snippet
Incorporating urea rebound using equilibrated urea concentration (C eq) after hemodialysis (HD) is essential for accurate assessment of HD efficiency. It is impractical to measure C eq in clinical settings, and there are no recommended methodologies to predict C eq in …
- 238000001631 haemodialysis 0 title abstract description 175
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris with membranes
- A61M1/1601—Control or regulation
- A61M1/1613—Profiling or modelling
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gotch et al. | Whither goest kt/v? | |
| Claure-Del Granado et al. | Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis | |
| US8303532B2 (en) | Pertioneal membrane function test method, peritoneal membrane function test apparatus and peritoneal membrane function test program | |
| Kuhlmann et al. | Accuracy and safety of online clearance monitoring based on conductivity variation | |
| Piccoli et al. | Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status | |
| Chauveau et al. | Dialyzer membrane permeability and survival in hemodialysis patients | |
| Ronco et al. | Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial | |
| Kong et al. | The effect of exercise during haemodialysis on solute removal | |
| Daugirdas et al. | Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study | |
| McIntyre et al. | Assessment of haemodialysis adequacy by ionic dialysance: intra‐patient variability of delivered treatment | |
| Aslam et al. | Online measurement of hemodialysis adequacy using effective ionic dialysance of sodium—a review of its principles, applications, benefits, and risks | |
| Maduell et al. | Impact of targeting K t instead of K t/V | |
| Chionh et al. | Acute peritoneal dialysis: what is the ‘adequate’dose for acute kidney injury? | |
| Casino et al. | Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules | |
| JP2016535644A (en) | Serum potassium therapy prediction and optimization for renal failure blood therapy, especially for home hemodialysis | |
| Churchill et al. | The nitty-gritties of kt/vurea calculations in hemodialysis and peritoneal dialysis | |
| Salahudeen et al. | Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients | |
| Ding et al. | Monitoring dialysis adequacy: history and current practice | |
| Tattersall et al. | Is Kt/V useful in elderly dialysis patients? Pro and Con arguments | |
| Mohamed et al. | Comparison of methods to estimate haemodialysis urea clearance | |
| Canaud et al. | Urea as a marker of adequacy in hemodialysis: lesson from in vivo urea dynamics monitoring | |
| Leypoldt et al. | Determinants of phosphorus mobilization during hemodialysis | |
| Ricci et al. | In vivo validation of the adequacy calculator for continuous renal replacement therapies | |
| Di Filippo et al. | Assessment of intradialysis calcium mass balance by a single pool variable‐volume calcium kinetic model | |
| Mercadal et al. | Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculation |